Inceptor Bio 宣布获得 3700 万美元的 A 系列融资,用于开发治疗难治性癌症的细胞疗法

积极 #投融资 #CAR#NK platforms#treat cancers#AMP#support advance
来源:www.prnewswire.com 发表于:2022-05-19
MORRISVILLE, N.C., May 19, 2022 /PRNewswire/ -- Inceptor Bio, a biotechnology company advancing cell therapies for difficult-to-treat cancers, today announced the closing of a $37 millio... 原文链接
本文新闻来源www.prnewswire.com,版权归原作者所有,内容仅代表作者本人观点,不代表企查查的立场。如有任何疑问或需要删除,请联系 kefu@qichacha.com